Merz Pharmaceuticals GmbH
Merz Pharmaceuticals GmbH
Explore linked clinical trials.6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury | Brain Injuries, Traumatic, Craniocerebral Trauma, brain disorder, brain injury, central nervous system disorder, injury, nervous system disorder, nervous system injury | Active, not recruiting | Phase 3 | 2026-09-24 | NCT03992404 | |
| Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Pelvic Pain Suggestive of Dysmenorrhea | primary dysmenorrhea | Recruiting | Phase 3 | 2026-07-13 | NCT06995287 | |
| Perineural Incobotulinumtoxin-A for Complex Regional Pain Syndrome - An Open-label Feasibility Study | autonomic nervous system disorder, complex regional pain syndrome, complex regional pain syndrome type 2, nervous system disorder, neuralgia, neuromuscular disease, peripheral nervous system disorder | Recruiting | Not applicable | 2026-03-16 | NCT07473635 | |
| Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities | Diabetes Complications, Diabetic Neuralgia, diabetes mellitus, diabetic neuropathy, endocrine system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder | Recruiting | Phase 2 | 2025-12-10 | NCT05623111 | |
| Xeomin® and Gait Related Mobility After Stroke | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 4 | 2025-11-25 | NCT04908423 | |
| DEgenerative ROtator Cuff Disease and Botulinum TOXin | Degenerative Rotator Cuff Disease | Recruiting | Phase 2 | 2025-06-27 | NCT05327972 |